140 related articles for article (PubMed ID: 14592456)
1. Sphingomyelin in the suppression of colon tumors: prevention versus intervention.
Lemonnier LA; Dillehay DL; Vespremi MJ; Abrams J; Brody E; Schmelz EM
Arch Biochem Biophys; 2003 Nov; 419(2):129-38. PubMed ID: 14592456
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treated with 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis.
Schmelz EM; Dillehay DL; Webb SK; Reiter A; Adams J; Merrill AH
Cancer Res; 1996 Nov; 56(21):4936-41. PubMed ID: 8895747
[TBL] [Abstract][Full Text] [Related]
3. Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice.
Dillehay DL; Webb SK; Schmelz EM; Merrill AH
J Nutr; 1994 May; 124(5):615-20. PubMed ID: 8169652
[TBL] [Abstract][Full Text] [Related]
4. Suppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones.
Schmelz EM; Bushnev AS; Dillehay DL; Liotta DC; Merrill AH
Nutr Cancer; 1997; 28(1):81-5. PubMed ID: 9200154
[TBL] [Abstract][Full Text] [Related]
5. Regulation of beta-catenin and connexin-43 expression: targets for sphingolipids in colon cancer prevention.
Simon KW; Roberts PC; Vespremi MJ; Manchen S; Schmelz EM
Mol Nutr Food Res; 2009 Mar; 53(3):332-40. PubMed ID: 18837472
[TBL] [Abstract][Full Text] [Related]
6. Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice.
Zhang P; Li B; Gao S; Duan RD
Anticancer Res; 2008; 28(6A):3631-5. PubMed ID: 19189644
[TBL] [Abstract][Full Text] [Related]
7. Ceramide-beta-D-glucuronide: synthesis, digestion, and suppression of early markers of colon carcinogenesis.
Schmelz EM; Bushnev AS; Dillehay DL; Sullards MC; Liotta DC; Merrill AH
Cancer Res; 1999 Nov; 59(22):5768-72. PubMed ID: 10582697
[TBL] [Abstract][Full Text] [Related]
8. Suppression of breast xenograft growth and progression in nude mice: implications for the use of orally administered sphingolipids as chemopreventive agents against breast cancer.
Simon KW; Tait L; Miller F; Cao C; Davy KP; LeRoith T; Schmelz EM
Food Funct; 2010 Oct; 1(1):90-8. PubMed ID: 21776459
[TBL] [Abstract][Full Text] [Related]
9. Colonic cell proliferation and aberrant crypt foci formation are inhibited by dairy glycosphingolipids in 1, 2-dimethylhydrazine-treated CF1 mice.
Schmelz EM; Sullards MC; Dillehay DL; Merrill AH
J Nutr; 2000 Mar; 130(3):522-7. PubMed ID: 10702579
[TBL] [Abstract][Full Text] [Related]
10. Sphingoid bases and ceramide induce apoptosis in HT-29 and HCT-116 human colon cancer cells.
Ahn EH; Schroeder JJ
Exp Biol Med (Maywood); 2002 May; 227(5):345-53. PubMed ID: 11976405
[TBL] [Abstract][Full Text] [Related]
11. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon.
Latham P; Lund EK; Johnson IT
Carcinogenesis; 1999 Apr; 20(4):645-50. PubMed ID: 10223194
[TBL] [Abstract][Full Text] [Related]
12. Anticancer compounds and sphingolipid metabolism in the colon.
Duan RD
In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
[TBL] [Abstract][Full Text] [Related]
13. Plant tannins inhibit the induction of aberrant crypt foci and colonic tumors by 1,2-dimethylhydrazine in mice.
Gali-Muhtasib HU; Younes IH; Karchesy JJ; el-Sabban ME
Nutr Cancer; 2001; 39(1):108-16. PubMed ID: 11588891
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by sphingosine, sphinganine, and C(2)-ceramide in human colon cancer cells, but not by C(2)-dihydroceramide.
Ahn EH; Schroeder JJ
Anticancer Res; 2010 Jul; 30(7):2881-4. PubMed ID: 20683027
[TBL] [Abstract][Full Text] [Related]
15. Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis.
Barnes CJ; Cameron IL; Hardman WE; Lee M
Br J Cancer; 1998 Feb; 77(4):573-80. PubMed ID: 9484814
[TBL] [Abstract][Full Text] [Related]
16. The potential of sphingomyelin as a chemopreventive agent in AOM-induced colon cancer model: wild-type and p53+/- mice.
Hu Y; Le Leu RK; Belobrajdic D; Young GP
Mol Nutr Food Res; 2008 May; 52(5):558-66. PubMed ID: 18324704
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of development of N,N'-dimethylhydrazine-induced rat colonic aberrant crypt foci by pre, post and simultaneous treatments with 24R,25-dihydroxyvitamin D3.
Salim EI; Wanibuchi H; Taniyama T; Yano Y; Morimura K; Yamamoto S; Otani S; Nishizawa Y; Morii H; Fukushima S
Jpn J Cancer Res; 1997 Nov; 88(11):1052-62. PubMed ID: 9439680
[TBL] [Abstract][Full Text] [Related]
18. Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids.
Schmelz EM; Roberts PC; Kustin EM; Lemonnier LA; Sullards MC; Dillehay DL; Merrill AH
Cancer Res; 2001 Sep; 61(18):6723-9. PubMed ID: 11559543
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
Au A; Li B; Wang W; Roy H; Koehler K; Birt D
Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
[TBL] [Abstract][Full Text] [Related]
20. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs.
Pereira MA
Adv Exp Med Biol; 1999; 470():55-63. PubMed ID: 10709674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
